Author

H. Boyaci

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biophysics· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Approach:biophysical modeling· 1 Assay:cryo-EM· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Research Focus:protein structure prediction· 1 Assay:structural biology· 1

Frequent Co-Authors

E. A. Campbell· 2 shared J. Chen· 2 shared R. Landick· 2 shared M. Lilic· 1 shared M. Palka· 1 shared R. A. Mooney· 1 shared S. A. Darst· 1 shared X. Cao· 1 shared

Activity by Year

2018-2022 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

E. A. Campbell

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Basis of narrow-spectrum activity of fidaxomicin on gut pathogen Clostridioides difficile

X. Cao, H. Boyaci, J. Chen, Y. Bao, R. Landick, E. A. Campbell

This study identifies the molecular basis of fidaxomicin's narrow-spectrum activity against Clostridioides difficile by analyzing its interaction with RNA polymerase.

bioRxiv · Jan 17, 2022 · PreprintMicrobiology

Fidaxomicin jams M. tuberculosis RNA polymerase motions needed for initiation via RbpA contacts

H. Boyaci, J. Chen, M. Lilic, M. Palka, R. A. Mooney, R. Landick, S. A. Darst, E. A. Campbell

This study determines the structure of M. tuberculosis RNA polymerase with fidaxomicin, revealing how it inhibits transcription by blocking essential motions.

bioRxiv · Jan 8, 2018Biophysics